University Hospital, Gentofte, Copenhagen
Clinical trials sponsored by University Hospital, Gentofte, Copenhagen, explained in plain language.
-
Can blocking the hunger hormone boost weight loss for semaglutide users?
Knowledge-focused Recruiting nowThis study looks at whether blocking the ghrelin (hunger) receptor can further reduce appetite in people with obesity who are already taking semaglutide. About 24 adults on a stable dose of semaglutide will receive either a natural blocker (LEAP2) or a placebo during two study vi…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Gentofte, Copenhagen • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Scientists investigate hormone combo for appetite control
Knowledge-focused Recruiting nowThis study looks at how two natural hormones, amylin and pancreatic polypeptide, affect hunger and food intake in healthy men. Over four separate days, 18 participants will receive different combinations of these hormones or a placebo. Researchers will measure how much they eat a…
Phase: NA • Sponsor: University Hospital, Gentofte, Copenhagen • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC
-
Hormone's role in post-meal blood pressure revealed
Knowledge-focused Recruiting nowThis study looks at how a natural hormone called GIP affects blood pressure after a meal in healthy adults aged 18-40. Researchers will measure blood pressure changes during a tilt test after giving either the hormone blocker or a placebo. The goal is to better understand the bod…
Phase: NA • Sponsor: University Hospital, Gentofte, Copenhagen • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC